Evangelia Vlachou, MD

Evangelia Vlachou, MD, a postdoctoral research fellow at Johns Hopkins Medicine.

Articles by Evangelia Vlachou, MD

Screenshot of an interview with Evangelia Vlachou, MD

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

February 14th 2025

Enfortumab vedotin with or without pembrolizumab offers disease control benefits for patients with upper tract urothelial cancer, said Evangelia Vlachou, MD, of Johns Hopkins Medicine.

Evangelia Vlachou, MD

Articles by Evangelia Vlachou, MD

Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer

Latest Updated Articles

Trending on AJMC

2025 Nobel Prize in Medicine Honors Discoveries Behind Regulatory T Cells

FDA Expands Roflumilast Use for Atopic Dermatitis to Children Aged 2 to 5 Years

Aggressive Therapy Recommendations Following the STRONG-HF Trials: Stephen J. Green, MD

Pricing and Insurance Networks in Outpatient Surgery Markets

Mediterranean Diet Improves Psoriasis Severity, Study Finds